Pladienolide D
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antineoplastic |
| Catalog number | BBF-05912 |
| CAS | 445487-91-2 |
| Molecular Weight | 552.7 |
| Molecular Formula | C30H48O9 |
| Catalog Number | Size | Price | Stock | Quantity |
|---|---|---|---|---|
| BBF-05912 | 50 mg | $6980 | In stock |
Online Inquiry
Add to cartCapabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Pladienolide D is an antitumor macrolide produced by Streptomyces platensis.
- Specification
- Properties
- Price Product List
| IUPAC Name | [(2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-2-[(2E,4E,6R)-6-hydroxy-7-[(2R,3R)-3-[(2R,3S)-3-hydroxypentan-2-yl]oxiran-2-yl]-6-methylhepta-2,4-dien-2-yl]-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] acetate |
| Canonical SMILES | CCC(C(C)C1C(O1)CC(C)(C=CC=C(C)C2C(C=CC(C(CCC(CC(=O)O2)O)(C)O)OC(=O)C)C)O)O |
| InChI | InChI=1S/C30H48O9/c1-8-23(33)20(4)28-24(38-28)17-29(6,35)14-9-10-18(2)27-19(3)11-12-25(37-21(5)31)30(7,36)15-13-22(32)16-26(34)39-27/h9-12,14,19-20,22-25,27-28,32-33,35-36H,8,13,15-17H2,1-7H3/b12-11+,14-9+,18-10+/t19-,20+,22+,23-,24+,25-,27+,28+,29-,30+/m0/s1 |
| InChI Key | SDUSVHUQNWGNCQ-MLQHUJDKSA-N |
| Antibiotic Activity Spectrum | Neoplastics (Tumor) |
| BBF-05806 | Zeaxanthin | Inquiry |
| BBF-05808 | Triptolide | Inquiry |
| BBF-04655 | Exatecan Mesylate | Inquiry |
| BBF-03516 | (±)-Naringenin | Inquiry |
| BBF-01732 | Mevastatin | Inquiry |
| BBF-05818 | Docosahexaenoic acid | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
